2017
DOI: 10.1007/s12539-017-0242-7
|View full text |Cite
|
Sign up to set email alerts
|

Identification of Strategic Residues at the Interface of Antigen–Antibody Interactions by In Silico Mutagenesis

Abstract: Structural information pertaining to antigen-antibody interactions is fundamental in immunology, and benefits structure-based vaccine design. Modeling of antigen-antibody immune complexes from co-crystal structures or molecular docking simulations provides an extensive profile of the epitope at the interface; however, the key amino acids involved in the interaction must be further clarified, often through the use of experimental mutagenesis and subsequent binding assays. Here, we describe an in silico mutagene… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
14
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(14 citation statements)
references
References 30 publications
0
14
0
Order By: Relevance
“…[39][40][41][42] The structure of EED was taken from the EED/EED226 complex structure (PDB ID: 5GSA). [39][40][41][42] The structure of EED was taken from the EED/EED226 complex structure (PDB ID: 5GSA).…”
Section: Protein-ligand Dockingmentioning
confidence: 99%
See 3 more Smart Citations
“…[39][40][41][42] The structure of EED was taken from the EED/EED226 complex structure (PDB ID: 5GSA). [39][40][41][42] The structure of EED was taken from the EED/EED226 complex structure (PDB ID: 5GSA).…”
Section: Protein-ligand Dockingmentioning
confidence: 99%
“…[33,34,42] Water molecules in the crystal structure were preserved. [33,34,42] Water molecules in the crystal structure were preserved.…”
Section: Molecular Dynamics Simulationsmentioning
confidence: 99%
See 2 more Smart Citations
“…These methods are fast, user-friendly, and reliable and promise to be invaluable in the development of proteins with a wide range of impactful applications. The applications of these tools extend from understanding the origin of diseases caused by misregulation of protein maintenance [ 51 , 52 ] to discriminating disease-associated mutations from non-disease mutations, studying drug-resistant mutations [ 53 , 54 , 55 ], and providing important structural and functional insights into designing new proteins [ 56 , 57 , 58 , 59 ]. To design DARPins as ERK2 inhibitors, a multi-point mutation approach, MAESTRO, was applied to the wild-type DARPin protein to identify the stabilizing mutation points, followed by validation of the binding energy of mutants employing MD simulations using MM-PBSA/GBSA protocols.…”
Section: Introductionmentioning
confidence: 99%